Screening for phaeochromocytoma in patients with acute cerebrovascular disease: Is it necessary?
Mohamed Zainuddin N, Sthaneshwar P, Ratnasingam J.
Malays J Pathol. 2020 Aug;42(2):203-207.
Heart and catecholamines.
Prichard BN, Owens CW, Smith CC, Walden RJ.
Acta Cardiol. 1991;46(3):309-22.
Pheochromocytoma triggered by coronavirus disease 2019: a case report.
Naghshineh H, Hasanpour A, Ziaei N, Sadeghi M, Meftah N.
J Med Case Rep. 2022 Jun 10;16(1):233. doi: 10.1186/s13256-022-03378-8.
Hypertensive emergencies.
Koch-Weser J.
N Engl J Med. 1974 Jan 24;290(4):211-4. doi: 10.1056/NEJM197401242900407.
Life-threatening events in patients with pheochromocytoma.
Riester A, Weismann D, Quinkler M, Lichtenauer UD, Sommerey S, Halbritter R, Penning R, Spitzweg C, Schopohl J, Beuschlein F, Reincke M.
Eur J Endocrinol. 2015 Dec;173(6):757-64. doi: 10.1530/EJE-15-0483. Epub 2015 Sep 7.
Progress in treatment and follow-up of pheochromocytoma.
Zhou Y, Tai Y, Shang J.
Eur J Surg Oncol. 2025 Aug;51(8):110144. doi: 10.1016/j.ejso.2025.110144. Epub 2025 May 10.
[von Hippel-Lindau disease--hemangioblastoma associated with pheochromocytoma].
Ohnishi T, Mori S, Motozaki T, Nagatani M, Bitoh S, Oku Y, Hayakawa T, Kamikawa K.
No Shinkei Geka. 1985 Jul;13(7):757-64.
BMSC-Exosomes attenuate ALP dysfunction by restoring lysosomal function via the mTOR/TFEB Axis to reduce cerebral ischemia-reperfusion injury.
Liu H, Li C, Zhang X, Chen H, Zhang Q, Zeng Y, Zheng S, Zou J, Zhao Y, Zheng X, Huang G, Zeng Q.
Exp Neurol. 2024 Jun;376:114726. doi: 10.1016/j.expneurol.2024.114726. Epub 2024 Feb 23.
Cardiovascular Manifestations and Complications of Pheochromocytomas and Paragangliomas.
Y-Hassan S, Falhammar H.
J Clin Med. 2020 Jul 30;9(8):2435. doi: 10.3390/jcm9082435.
Causes of death in patients with malignant adrenal tumours: a population-based analysis.
Zheng Y, Ren S, Yan Z, Hu T, Feng Y, Wang D, Fan S, Ren S.
J Endocrinol Invest. 2025 Jun;48(6):1415-1431. doi: 10.1007/s40618-025-02555-y. Epub 2025 Feb 24.
